A Phase III Randomized Trial of the Timing of Meloxicam With Iodine-125 Prostate Brachytherapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A Phase III Randomized Trial of the Timing of Meloxicam With Iodine-125 Prostate Brachytherapy

Published:2010-06 Issue:2 Volume:77 Page:496-501
ISSN:0360-3016
Container-title:International Journal of Radiation Oncology*Biology*Physics
language:en
Short-container-title:International Journal of Radiation Oncology*Biology*Physics

Author:

Crook Juanita,Patil Nikhilesh,Wallace Kris,Borg Jette,Zhou David,Ma Clement,Pond Greg

Publisher

Elsevier BV

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology,Radiation

Reference36 articles.

1. 12-year outcomes following permanent prostate brachytherapy in patients with clinically localized prostate cancer;Potters;J Urol,2008

2. Brachytherapy for carcinoma of the prostate: Techniques, patient selection, and clinical outcomes;Blasko;Semin Radiat Oncol,2002

3. Celecoxib to decrease urinary retention associated with prostate brachytherapy;Feigenberg;Brachytherapy,2003

4. The efficacy of premedication with celecoxib and acetaminophen in preventing pain after otolaryngologic surgery;Issioui;Anesth Analg,2002

5. The preemptive analgesic effect of rofecoxib after ambulatory arthroscopic knee surgery;Reuben;Anesth Analg,2002

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Fatty acids in cancer: Metabolic functions and potential treatment;MedComm – Oncology;2023-03

2. Low dose rate brachytherapy for primary treatment of localized prostate cancer: A systemic review and executive summary of an evidence-based consensus statement;Brachytherapy;2021-11

3. Complications and side effects of high-dose-rate prostate brachytherapy;Brachytherapy;2021-09

4. Analysis of quality of life after randomized controlled trial of alpha-1 adrenoceptor antagonist alone and in combination with cyclooxygenase-2 inhibitor in patients who underwent low-dose-rate brachytherapy for prostate cancer;Journal of Contemporary Brachytherapy;2019

5. Genitourinary Cancers;Absolute Clinical Radiation Oncology Review;2019

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3